Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ-0,39
KB-0,38
PKN101,75101,85-0,39
Msft147,77147,780,32
Nokia3,033,05-4,87
IBM133,99134,01-0,36
Daimler AG51,1951,21-4,48
PFE36,5636,57-0,10
14.11.2019 20:21:38
Indexy online
AD Index online
select
AD Index online
 

  • 14.11.2019 20:21:11
Becton Dickinson (BDX, NY Consolidated)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (ks)
249,37 0,95 2,36 578 255
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 14.11.2019
Popis společnosti
Obecné informace
Název společnostiBecton Dickinson and Co
TickerBDX
Kmenové akcie:Ordinary Shares
RICBDX
ISINUS0758871091
Prioritní akcieConv. Pref. Shrs
Poslední známé roční výsledky30.09.2019
Poslední známé čtvrtletní výsledky30.09.2019
Počet zaměstnanců k 30.09.2018 76 032
Akcie v oběhu k 30.09.2019 269 954 141
MěnaUSD
Konstituent indexůS&P 500
Kontaktní informace
Ulice1 Becton Dr
MěstoFRANKLIN LAKES
PSČ07417-1815
ZeměUnited States
Kontatní osobaMonique Dolecki
Funkce kontaktní osobyIR Contact Officer
Telefon12 018 476 800
Kontatní telefon12 018 475 378

Business Summary: Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including diabetes care, medication and procedural solutions, medication management solutions and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Life Sciences segment consists of various business units, including preanalytical systems, diagnostic systems and biosciences.
Financial Summary: BRIEF: For the fiscal year ended 30 September 2019, Becton Dickinson and Co revenues increased 8% to $17.29B. Net income applicable to common stockholders excluding extraordinary items increased 27% to $1.02B. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Interest expense decrease of 9% to $639M (expense).
Odvětvová klasifikace
TRBC2009Medical Equipment / Supplies / Distribution
TRBC2012Medical Supplies
RBSS2004Medical Equipment, Supplies & Distribution
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSSurgical and Medical Instrument Manufacturing
NAICSSurgical Appliance and Supplies Manufacturing
NAICSAnalytical Laboratory Instrument Manufacturing
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
SICSurgical And Medical Instruments
SICSurgical And Medical Instruments
SICSurgical Appliances And Supplies
SICAnalytical Instruments
SICElectromedical Equipment



  • Poslední aktualizace: 14.11.2019
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board, Chief Executive OfficerVincent Forlenza6523.04.2017
President, Chief Operating OfficerThomas Polen4601.10.201801.10.2014
Chief Financial Officer, Executive Vice President, Chief Administrative OfficerChristopher Reidy6115.07.201315.07.2013
Executive Vice President- Human Resources, Chief Human ResourcesBetty Larson42
Executive Vice President, General CounselSamrat Khichi51
Executive Vice President - Global Operations, Chief Supply Chain OfficerJames Borzi50
Executive Vice President and President, BD Interventional SegmentSimon Campion4704.09.201804.09.2018
Executive Vice President, President - EMEARoland Goette56
Executive Vice President, President - Life SciencesPatrick Kaltenbach5529.05.201829.05.2018
Executive Vice President and President, Greater AsiaChing leong54